Real-World Experience of
NTRK
Fusion-Positive Thyroid Cancer
JCO Precis Oncol
.
2022 Feb:6:e2100442.
doi: 10.1200/PO.21.00442.
Authors
Jong Chul Park
1
,
Arya Ashok
2
,
Chienying Liu
3
,
Hyunseok Kang
3
Affiliations
1
Department of Medicine, Massachusetts General Hospital/Harvard Medical School, Boston, MA.
2
Medical Affairs, Tempus, Phoenix, AZ.
3
Department of Medicine, University of California, San Francisco, San Francisco, CA.
PMID:
35171659
PMCID:
PMC8865519
DOI:
10.1200/PO.21.00442
No abstract available
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
Humans
Receptor, trkC
Thyroid Neoplasms* / genetics
Substances
Receptor, trkC